Missing/wrong data?
Log in to edit
A phase I trial of ISIS 2503, an antisense inhibitor of H-ras, in combination with gemcitabine in patients with advanced cancer.
scientific article
Author/s
author: Henry C Pitot, Grace K Dy, Alex A Adjei, Lorelei J Hanson, Charles Erlichman, Pamela J Atherton, Steven R Alberts, Joel M Reid, Jeff A Sloan
Work details
Publication date
January 1, 2003
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.